Traumatic Brain Injury, Part I

Section 1 Risk and Predisposition 1. Epidemiology 2. Classification of traumatic brain injury: past, present and future 3. Genetic predictors of outcome following TBISection 2 Pathology and Mechanisms of Traumatic Brain Injury 4. The neuropathology of traumatic brain injury 5. Cellular and Molecular Mechanisms of Injury and Spontaneous Recovery 6. Injury biomechanics, neuropathology, and simplified physics of explosive blast and impact mild traumatic brain injury 7. Cellular biomechanics of central nervous system injury 8. Animal models of traumatic brain injurySection 3 Special Considerations 9. Mild traumatic brain injury 10. Acute sports-related traumatic brain injury and repetitive concussion 11. Brain injury from explosive blast: description and clinical management 12. Surgical management of civilian gunshot wounds to the head 13. Acute Loss of Consciousness 14. Systemic manifestations of traumatic brain injury 15. Special Considerations in Infants and ChildrenSection 4 Current and Emerging Diagnostic Tools 16. Biomarkers 17. Current and future diagnostic tools for traumatic brain injury: CT, conventional MRI, and diffusion tensor imaging 18. Using fMRI and EEG to detect consciousness after severe brain injury 19. Resting Functional Imaging Tools: (MRS, SPECT, PET and PCT) 20. Advances in imaging explosive blast mild traumatic brain injury 21. Electrophysiological recordings in traumatic brain injurySection 5 Management and Treatment 22. Neuroprotection for traumatic brain injury 23. The prehospital management of traumatic brain injury 24. Acute Management of Military-Related Injury (PHI & Blast) 25. Clinical Management of the Minimally Conscious State 26. Rehabilitation after traumatic brain injury 27. Long-Term Social Integration and Community Support 28. Recent developments in clinical trials for the treatment of traumatic brain injury

Dr. Grafman has been the director of Brain Injury Research at the Shirley Ryan AbilityLab ((SRALab)formally known as the Rehabilitation Institute of Chicago) since 2012 and is on faculty at Northwestern University's Feinberg School of Medicine in the Departments of Physical Medicine and Rehabilitation, Neurology, Psychiatry and Behavioral Sciences, and the Cognitive Neurology and Alzheimer's Disease Center as well as the Department of Psychology in the Weinberg College of Arts and Sciences. Before joining the SRALab, Dr. Grafman was briefly director of Traumatic Brain Injury Research at the Kessler Foundation in West Orange New Jersey. Prior to that appointment in 2011, Dr. Grafman was Chief of the Cognitive Neuroscience Section at the National Institute of Neurological Disorders and Stroke in Bethesda, Maryland for many years. His investigation of brain function and behavior contributes to advances in medicine, rehabilitation, and psychology, and informs ethics, law, philosophy,and health policy. His study of the human prefrontal cortex and cognitive neuroplasticity incorporates neuroimaging and genetics, an approach that is expanding our knowledge of the functions of the human frontal lobes, as well as the effects of neurological disorders that impair frontal lobe brain function.